- ￥2588 - 7788
- abinScience
- France
- HC336066
- 2026年09月04日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
源叶生物 十万种现货试剂速发，品质稳、品类全，实验不再等！Takara 秋促来袭，提取+反转录+定量套装仅 1200 元abinScience 体内级抗体 全年锁价 低至 ￥1200阿拉丁 22万+ 科研级产品现货速发，品质严控、科研无忧- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
-20℃
- 保质期：
12 months
- 供应商：
武汉研升生物科技有限公司
- 规格：
100μg/1mg
| 规格： | 100μg | 产品价格： | ￥2588.0 |
|---|---|---|---|
| 规格： | 1mg | 产品价格： | ￥7788.0 |
| 产品名称 | Research Grade Anti-Human CD137/TNFRSF9/4-1BB (EU101) |
| 货号 | HC336066 |
| 描述 | Anti-Human CD137/TNFRSF9/4-1BB (EU101) ( HC336066 ) is a research-grade recombinant antibody targeting CD137 . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade — For PK/PD studies, assay development, and ADA research. Native Glycosylation — Mammalian expression ensures native-like patterns. |
| 反应种属 | Human |
| 应用实验 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| 宿主/表达体系 | Human |
| 靶点 | Tumor necrosis factor receptor superfamily member 9, CD137, 4-1BB ligand receptor, CDw137, TNFRSF9, T-cell antigen ILA, T-cell antigen 4-1BB homolog, ILA |
| 基因号 | Q07011 |
| 状态 | Liquid |
| 纯度 | >95% purity as determined by SDS-PAGE. |
| 储存温度 | -20℃ |
| 别名 | EU101 |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验【第101期】前沿靶点速递｜谁最可能率先成药？13个潜在靶点盘点
大学湘雅医院刘振华副教授等在Advanced Science发表了一篇研究，鉴定出TMEM175基因----个转运缺陷型错义变异L156P，系统阐明了TMEM175-L156P突变蛋白滞留于内质网、无法正确转运至溶酶体，导致溶酶体酸性稳态失衡和降解功能受损的分子机制。团队通过筛选和结构优化，开发了螺环骨架分子DCY-09-X，兼具分子伴侣和通道激活双功能，既能将L156P护送至溶酶体，又能激活其通道功能，为帕金森病精准治疗提供了新策略。 05 靶点：PRPF6 应用：视网膜色素变性的潜在治疗靶点来源：AAV
Cryopreservation of Human Hepatocytes for Clinical Use
Cryopreservation of hepatocytes is important for use both in research and for clinical application in hepatocyte transplantation. Cryopreservation causes damage to hepatocytes with the result that cell viability and function is reduced
Discovery Genetics: The History and Future of Spontaneous Mutation Research
as valuable models of heritable human diseases, contributing substantially to our understanding of both disease mechanisms and basic biological pathways. While advances in molecular technologies have improved our ability to create mouse models of human disease
技术资料暂无技术资料 索取技术资料
